MJ Keating

Statistics

Publications

Citations

751

H-Index

Active since

1981

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

MJ Keating is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, hematologic malignancy therapy, and oncology.

Publications per year

1981–2000

Publications

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

MJ Keating, H. Kantarjian, Moshe Talpaz et al. · Blood · 1989 · 456 citations · Full text

Medicine, Oncology, Pharmacology +9

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

SM Escudier, JM Pereira-Leahy, JW Drach et al. · Blood · 1993 · 111 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

Peng Huang, Alex Sandoval, Eric Van Den Neste et al. · Leukemia · 2000 · 88 citations

Life Sciences, Molecular Biology, Pharmacology +12

Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)

MJ Keating, KB McCredie, RS Benjamin et al. · Blood · 1981 · 79 citations

Medicine, Oncology, Pharmacology +14

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia

Stefano Sacchi, HM Kantarjian, Stephen J. O’Brien et al. · Leukemia · 1997 · 17 citations · Full text

Medicine, Hematology, Oncology +8

1–5 of 5